Your browser doesn't support javascript.
loading
Factors associated with atherosclerosis in radiographic and non-radiographic axial spondyloarthritis. A multicenter study on 838 patients.
Rueda-Gotor, Javier; Ferraz-Amaro, Iván; Genre, Fernanda; González-Mazón, Iñigo; Corrales, Alfonso; Calvo-Rio, Vanesa; Portilla, Virginia; Llorca, Javier; Expósito, Rosa; Hernández-Hernández, Vanesa; Quevedo-Abeledo, Juan Carlos; Rodríguez-Lozano, Carlos; Lopez-Medina, Clementina; Ladehesa-Pineda, María Lourdes; Castañeda, Santos; Vicente, Esther F; Fernández-Carballido, Cristina; Martínez-Vidal, M Paz; Castro-Corredor, David; Anino-Fernández, Joaquín; Peiteado, Diana; Plasencia-Rodríguez, Chamaida; García-Vivar, María Luz; Galíndez-Agirregoikoa, Eva; Montes-Perez, Esther; Fernández-Díaz, Carlos; Blanco, Ricardo; González-Gay, Miguel Ángel.
Afiliação
  • Rueda-Gotor J; Rheumatology Division, Hospital Sierrallana, Torrelavega, Spain; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain. Electronic address: ruedagotor@gmail.com.
  • Ferraz-Amaro I; Rheumatology Division, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.
  • Genre F; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain.
  • González-Mazón I; Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.
  • Corrales A; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain; Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.
  • Calvo-Rio V; Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.
  • Portilla V; Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.
  • Llorca J; Department of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, CIBER Epidemiología y Salud Pública (CIBERESP), IDIVAL, Santander, Spain.
  • Expósito R; Division of Rheumatology, Hospital Comarcal, Laredo, Cantabria, Spain.
  • Hernández-Hernández V; Rheumatology Division, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.
  • Quevedo-Abeledo JC; Rheumatology Division, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain.
  • Rodríguez-Lozano C; Rheumatology Division, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain.
  • Lopez-Medina C; Rheumatology Division, Hospital Universitario Reina Sofía, Córdoba, Spain.
  • Ladehesa-Pineda ML; Rheumatology Division, Hospital Universitario Reina Sofía, Córdoba, Spain.
  • Castañeda S; Rheumatology Division, Hospital Universitario de La Princesa, IIS-Princesa, Madrid, Spain.
  • Vicente EF; Rheumatology Division, Hospital Universitario de La Princesa, IIS-Princesa, Madrid, Spain.
  • Fernández-Carballido C; Rheumatology Division, Hospital Universitario de San Juan, Alicante, Spain.
  • Martínez-Vidal MP; Rheumatology Division, Hospital General Universitario de Alicante, Alicante, Spain.
  • Castro-Corredor D; Rheumatology Division, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain.
  • Anino-Fernández J; Rheumatology Division, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain.
  • Peiteado D; Rheumatology Division, Hospital La Paz, Madrid, Spain.
  • Plasencia-Rodríguez C; Rheumatology Division, Hospital La Paz, Madrid, Spain.
  • García-Vivar ML; Rheumatology Division, Hospital Universitario Basurto, Bilbao, Spain.
  • Galíndez-Agirregoikoa E; Rheumatology Division, Hospital Universitario Basurto, Bilbao, Spain.
  • Montes-Perez E; Diagnóstico Médico Cantabria (DMC), Santander, Spain.
  • Fernández-Díaz C; Rheumatology división, Hospital Universitario Reina Sofía, Murcia, Spain.
  • Blanco R; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain; Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.
  • González-Gay MÁ; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain; Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain; School of Medicine, University of Cantabria, Santander, Spain; University of the Witwa
Semin Arthritis Rheum ; 55: 152037, 2022 08.
Article em En | MEDLINE | ID: mdl-35689912
ABSTRACT

OBJECTIVES:

To identify disease-related factors associated with subclinical atherosclerosis and cardiovascular (CV) events in a large series of patients with axial spondyloarthritis (axSpA) and to identify possible differences in the effect of the potential pro-atherogenic factors between ankylosing spondylitis (AS) non-radiographic axSpA (nr-axSpA).

METHODS:

This is a cross-sectional observational study of the AtheSpAin cohort, a Spanish multicenter cohort to study atherosclerosis in axSpA. Subclinical atherosclerosis determined by carotid ultrasound included assessment of carotid intima-media thickness (cIMT) and plaque detection.

RESULTS:

639 AS and 167 nr-axSpA patients were recruited. CV risk factors (CRF) and several disease-related factors showed a statistically significant association with subclinical atherosclerosis in the crude analysis. After adjustment for age, sex, and smoking (model 1), associations remained statistically significant for spinal mobility, inflammatory bowel disease, use of prednisone, and Disease-modifying antirheumatic drugs (DMARD) when assessing carotid plaques and for acute phase reactants (APR) at diagnosis, use of prednisone, DMARD, and TNF-inhibitors when measuring cIMT. In model 2, which also included classic CRF as confounding factors to identify axSpA features with a potential independent pro-atherogenic effect, the functional status was the only variable significantly associated with plaques and the use of prednisone and APR at diagnosis with cIMT. No association differences were found between both subtypes of patients. Besides, APR at diagnosis were also associated with subsequent development of CV events that had occurred in 33 patients.

CONCLUSION:

Apart from CRF, atherosclerotic disease in AxSpA is associated with disease-related factors such as inflammatory response and disease severity, with no differences between AS and nr-axSpA.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espondilite Anquilosante / Antirreumáticos / Espondilartrite / Aterosclerose / Espondiloartrite Axial / Espondiloartrite Axial não Radiográfica Tipo de estudo: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espondilite Anquilosante / Antirreumáticos / Espondilartrite / Aterosclerose / Espondiloartrite Axial / Espondiloartrite Axial não Radiográfica Tipo de estudo: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article